EVR Research’s MaxLinear MXL Stock Holding History

EVR Research’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-560,000	Closed	-$8.11M	–	44
2024 Q3	$8.11M	Buy	+560,000	New	+$8.89M	2.02%	20

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

PHK

Point72 Hong Kong Hong Kong $2.18B AUM 89.02% 1-Year Est. Return

EVR Research's MXL Position: Q4 2024 in Review

EVR Research sold out of MaxLinear (MXL) in Q4 2024, closing a stake of 560,000 shares — an estimated $8.11M sold.

EVR Research first reported a position in MXL in Q3 2024 and held it in 1 quarter. The position peaked at $8.11M in Q3 2024. 209 funds tracked by Wall St. Rank hold MXL as of Q4 2024.

EVR Research reported no remaining MaxLinear position as of Q4 2024 after selling out during the quarter.
EVR Research sold 560,000 MaxLinear shares in Q4 2024, an estimated $8.11M.
EVR Research first reported a position in MaxLinear in Q3 2024 and held it in 1 quarter.
EVR Research's MaxLinear position peaked at $8.11M in Q3 2024.
209 funds tracked by Wall St. Rank held MaxLinear as of Q4 2024.

Based on EVR Research's 13F filing for Q4 2024, filed 13 Feb 2025.